- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Investors pour $25M into telerad firm
NightHawk Radiology Holdings, a provider of off-hour teleradiology services to U.S. facilities, has received a $25 million investment from Summit Partners, a private equity and venture capital firm. The teleradiology provider, based in Coeur D'Alene, ID,
NightHawk Radiology Holdings, a provider of off-hour teleradiology services to U.S. facilities, has received a $25 million investment from Summit Partners, a private equity and venture capital firm. The teleradiology provider, based in Coeur D'Alene, ID, employs U.S.-trained American Board of Radiology-certified physicians to provide preliminary radiological interpretations from a central reading facility in Sydney, Australia. The physicians electronically receive, read, and respond to the submitted radiology scans in a transcribed report sent to the attending physician. Staff read more than 1500 scans per night, providing service to more than 350 hospitals, radiology groups, and clinics.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
